The National Times - New crew set to launch for ISS after medical evacuation

New crew set to launch for ISS after medical evacuation


New crew set to launch for ISS after medical evacuation
New crew set to launch for ISS after medical evacuation / Photo: © AFP/File

Four astronauts could blast off to the International Space Station (ISS) next week, after setbacks including a mysterious medical evacuation of the previous crew, last-minute rocket problems, and some scheduling conflicts with NASA's Moon mission.

Change text size:

The crew was scheduled to launch on February 11, Elon Musk's SpaceX company said this week it was grounding all flights on its Falcon 9 rocket while it investigates an unspecified issue.

This late uncertainty is just the most recent twist for the SpaceX Crew-12 mission, which includes Americans Jessica Meir and Jack Hathaway, French astronaut Sophie Adenot and Russian cosmonaut Andrey Fedyaev.

They will be replacing Crew-11, which returned to Earth in January, a month earlier than planned, during the first medical evacuation in the space station's history.

NASA has declined to disclose any details about the health issue that cut the mission short.

However, the scientific laboratory, which orbits 400 kilometres above Earth, has since been staffed by a skeleton crew of three.

Because of the medical evacuation, NASA moved the date of the Crew-12 launch forward a few days.

The launch had also overlapped with NASA's first mission to fly astronauts around the Moon in more than half a century.

The launch window for the Artemis 2 mission had been set for February 6-11 -- until leaks detected this week during final tests pushed the date back to March 6.

- 'One day, that will be me' -

Once the astronauts finally get on board, they will be one of the last crews to live on board the football field-sized space station.

Continuously inhabited for the last quarter century, the ageing ISS is scheduled to be pushed into Earth's orbit before crashing into an isolated spot in the Pacific Ocean in 2030.

The ISS, once a symbol of warming post-Cold War relations, has been a rare area of continued cooperation between the West and Russia since Moscow invaded Ukraine in 2022.

However, the space station has not entirely avoided the tensions back on Earth.

In November, Russian cosmonaut Oleg Artemyev -- who had long been planned to be a member of Crew-12 -- was suddenly taken off the mission.

Reports from independent media in Russia suggested he had been photographing and sending classified information with his phone. Russian space agency Roscosmos merely said he had been transferred to a different job.

His replacement Fedyaev, has already spent some time on the ISS as part of Crew-6 in 2023.

During their eight months on the space station, the four astronauts will conduct many experiments, including research into the effects of microgravity on their bodies.

Meir, who previously worked as a marine biologist studying animals in extreme environments, will serve as the crew's commander.

Adenot will become the second French woman to fly to space, following in the footsteps of Claudie Haignere, who spent time on the Mir space station.

When Adenot saw Haignere's mission blast off, she was 14 years old.

"It was a revelation," the helicopter pilot said recently.

"At that moment, I told myself: one day, that will be me."

Among other research, the European Space Agency astronaut will test a system that uses artificial intelligence and augmented reality to allow astronauts to carry out their own medical ultrasounds.

The mission is scheduled to launch from Cape Canaveral, Florida at 1100 GMT on February 11. If called off, launches can also be attempted on the following two days.

H.Davies--TNT

Featured

Nearly 1,100 flights cancelled after UK air traffic control glitch

Almost 1,100 flights to and from UK airports were cancelled Tuesday due to what the country's air traffic control service called a technical issue, in the latest glitch to spark travel chaos.

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Change text size: